Apr 3, 2022
Evasion of COVID-19 vaccine-medicated mucosal immunity by SARS-CoV-2 Omicron
In a recent study posted to the medRxiv* preprint server, researchers depicted the evasion of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant to mucosal immunity in SARS-CoV-2 vaccine recipients. Study: Escape of SARS-CoV-2 variant Omicron to mucosal immunity in vaccinated subjects. Image Credit: Studio Romantic/Shutterstock Background The SARS-CoV-2 Omicron (B.1.1.529) variant has swiftly